What are the leading hepatitis concept stocks in 2023
At 11:26 on December 7, the hepatitis concept sector index reported 1218.67 points, an increase of 4%, with a transaction volume of 11.184 billion yuan, and changed hands The rate is 4.67%. So today the editor is here to sort out for you what are the leading stocks with hepatitis concepts, let’s take a look!
Anbiping 688393
Guangzhou Anbiping Pharmaceutical Technology Co., Ltd. Mainly engaged in the research and development, production and sales of in vitro diagnostic reagents and instruments. The company's main products are in vitro diagnostic reagents and diagnostic instruments.
The company has established a marketing network covering 31 provinces (municipalities and autonomous regions) nationwide, providing services to more than 1,800 medical institutions across the country, including more than 900 third-level hospitals and more than 600 third-level hospitals. The company's end customers include many domestic authoritative hospitals, and the quality of its products and services has been widely recognized by customers.
ST Tai'an 002433
Guangdong Taiantang Pharmaceutical Co., Ltd. is mainly engaged in the research, development, production and sales of drugs; the cultivation, processing and sales of Chinese medicinal materials; and pharmaceutical e-commerce. At present, the company has 18 dosage form production lines including creams, ointments, tablets, capsules, pills, solutions (external use), etc., has nearly 400 drug approval numbers, and 25 exclusive products, including Qilin Pills, Qubishu Jianwan pills, Xinbao pills, Xinxin pills, Tongqiao Yixin pills, Shenqinaokang capsules, Dantian Jiangzhi pills, anti-inflammatory ringworm wet ointment and other varieties.
"Kirin Pill Making Technique" has been awarded the "National Intangible Cultural Heritage" certificate by the Ministry of Culture and the Ministry of Culture. The company's exclusive patented variety, Qilin Pills, is a clinically advantageous proprietary Chinese medicine approved by NMPA that can be taken by both men and women. Its production technology has been included in the national intangible cultural heritage representative project protection list.
Yahuilong 6888575
The main business of Shenzhen Yahuilong Biotechnology Co., Ltd. is the research and development of in vitro diagnostic instruments and supporting reagents based on chemiluminescence immunoassay. Production and sales, the main products include iFlash3000 series chemiluminescence analyzers, iFlash1800 series chemiluminescence immunoassay analyzers, iModules fully automatic immunoassay assembly line, UNION series immunoanalyzers, TenflyBlot series protein blotters, TenflyAuto series fully automatic immunoblot analyzers, TenflyPhoenix fully automatic immunoblotting analyzer, UNICELL-S single-channel dry fluorescence immunoassay analyzer, UNICELL-M12 channel dry fluorescence immunoassay analyzer, VISION series fully automatic dynamic erythrocyte sedimentation rate analyzer, VISIONPro series fully automatic dynamic erythrocyte sedimentation rate analyzer, iTLA Automatic sample processing system, iCube intelligent laboratory information system, the company won the "National Intellectual Property Advantage Enterprise", "IVD In Vitro Diagnostics Most Investment Value Brand", "China's 'Star' Cup In Vitro Diagnostic Reagent Outstanding Innovative Product" Award" and other honorary titles.
Foci Pharmaceutical 002644
The main business of Lanzhou Foci Pharmaceutical Co., Ltd. is the research and development, manufacturing and sales of Chinese patent medicines and general health products. The cultivation and sales of Chinese herbal medicines, and the processing of Chinese herbal medicine pieces. and sales, production and sales of protective masks and other medical devices. The company's main products include a series of Chinese patent medicines such as Liuwei Dihuang Pills, Xiaoyao Pills, Xiangsha Yangwei Pills, Shenrong Gubenhuanshao Pills, and other major health products such as donkey-hide gelatin and donkey-hide gelatin cake.
The company’s exclusive product, Shugan Xiaoji Pills, has the effects of resisting liver damage, improving blood rheology, and improving immune function. It can be used for chronic hepatitis B, liver stagnation and spleen deficiency, internal dampness and heat, qi stagnation and blood stasis. The symptoms include: hypochondriac pain, epigastric distension and stuffiness, disgust with greasy food, nausea and vomiting, fatigue and weakness, etc. It is mostly used clinically for chronic hepatitis B caused by liver stagnation and qi stagnation.